1. ICER says AbbVie’s Rinvoq for RA may be cost-effective but still questions the value of JAK class — Gilead, Galapagos share 52-week update on filgotinib — UPS gets clearance to expand medical drone delivery service across US — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Biotech Startups

Anonymous board for discussion of biotech startups


Sort By:
Title
Replies Views
Last Message ↓
  1. anonymous
    Replies:
    2
    Views:
    597
  2. anonymous
    Replies:
    Views:
    N/A
  3. anonymous
    Replies:
    2
    Views:
    836
  4. anonymous
    Replies:
    0
    Views:
    1,115
  5. anonymous
    Replies:
    1,211
    Views:
    175,851
  6. anonymous
    Replies:
    1
    Views:
    2,019
  7. anonymous
    Replies:
    9
    Views:
    4,884
  8. anonymous
    Replies:
    91
    Views:
    18,468
  9. anonymous
    Replies:
    Views:
    N/A
  10. anonymous
    Replies:
    Views:
    N/A
  11. anonymous
    Replies:
    4
    Views:
    4,034
  12. anonymous
    Replies:
    2
    Views:
    1,291
  13. anonymous
    Replies:
    5
    Views:
    1,316
  14. anonymous
    Replies:
    33
    Views:
    17,713
  15. anonymous
    Replies:
    1
    Views:
    1,227
  16. anonymous
    Replies:
    17
    Views:
    8,643
  17. anonymous
    Replies:
    6
    Views:
    8,019
  18. anonymous
    Replies:
    15
    Views:
    7,526
  19. anonymous
    Replies:
    67
    Views:
    10,214
  20. anonymous
    Replies:
    1
    Views:
    1,415

Thread Display Options

Loading...